Lithium
45.22
0.51%
Gold
2,738.70
(0.5%)
Copper
4.38
(2.03%)
Oil
70.80
(1.69%)
Bitcoin
72,887.10
5.07%
FTSE 100
8,277.85
1.29%
Nikkei 225
39,480.67
2.08%
Dow Jones
42,221.88
0.92%
Iron Ore
104.20
(1.13%)
USD/AUD
0.66
(0.9%)
Hang Seng
20,538.38
(1.22%)
Lithium
45.22
0.51%
Gold
2,738.70
(0.5%)
Copper
4.38
(2.03%)
Oil
70.80
(1.69%)
Bitcoin
72,887.10
5.07%
FTSE 100
8,277.85
1.29%
Nikkei 225
39,480.67
2.08%
Dow Jones
42,221.88
0.92%
Iron Ore
104.20
(1.13%)
USD/AUD
0.66
(0.9%)
Hang Seng
20,538.38
(1.22%)
Lithium
45.22
0.51%
Gold
2,738.70
(0.5%)
Copper
4.38
(2.03%)
Oil
70.80
(1.69%)
Bitcoin
72,887.10
5.07%
FTSE 100
8,277.85
1.29%
Nikkei 225
39,480.67
2.08%
Dow Jones
42,221.88
0.92%
Iron Ore
104.20
(1.13%)
USD/AUD
0.66
(0.9%)
Hang Seng
20,538.38
(1.22%)
Lithium
45.22
0.51%
Gold
2,738.70
(0.5%)
Copper
4.38
(2.03%)
Oil
70.80
(1.69%)
Bitcoin
72,887.10
5.07%
FTSE 100
8,277.85
1.29%
Nikkei 225
39,480.67
2.08%
Dow Jones
42,221.88
0.92%
Iron Ore
104.20
(1.13%)
USD/AUD
0.66
(0.9%)
Hang Seng
20,538.38
(1.22%)
Lithium
45.22
0.51%
Gold
2,738.70
(0.5%)
Copper
4.38
(2.03%)
Oil
70.80
(1.69%)
Bitcoin
72,887.10
5.07%
FTSE 100
8,277.85
1.29%
Nikkei 225
39,480.67
2.08%
Dow Jones
42,221.88
0.92%
Iron Ore
104.20
(1.13%)
USD/AUD
0.66
(0.9%)
Hang Seng
20,538.38
(1.22%)
Lithium
45.22
0.51%
Gold
2,738.70
(0.5%)
Copper
4.38
(2.03%)
Oil
70.80
(1.69%)
Bitcoin
72,887.10
5.07%
FTSE 100
8,277.85
1.29%
Nikkei 225
39,480.67
2.08%
Dow Jones
42,221.88
0.92%
Iron Ore
104.20
(1.13%)
USD/AUD
0.66
(0.9%)
Hang Seng
20,538.38
(1.22%)
Lithium
45.22
0.51%
Gold
2,738.70
(0.5%)
Copper
4.38
(2.03%)
Oil
70.80
(1.69%)
Bitcoin
72,887.10
5.07%
FTSE 100
8,277.85
1.29%
Nikkei 225
39,480.67
2.08%
Dow Jones
42,221.88
0.92%
Iron Ore
104.20
(1.13%)
USD/AUD
0.66
(0.9%)
Hang Seng
20,538.38
(1.22%)
Lithium
45.22
0.51%
Gold
2,738.70
(0.5%)
Copper
4.38
(2.03%)
Oil
70.80
(1.69%)
Bitcoin
72,887.10
5.07%
FTSE 100
8,277.85
1.29%
Nikkei 225
39,480.67
2.08%
Dow Jones
42,221.88
0.92%
Iron Ore
104.20
(1.13%)
USD/AUD
0.66
(0.9%)
Hang Seng
20,538.38
(1.22%)
Lithium
45.22
0.51%
Gold
2,738.70
(0.5%)
Copper
4.38
(2.03%)
Oil
70.80
(1.69%)
Bitcoin
72,887.10
5.07%
FTSE 100
8,277.85
1.29%
Nikkei 225
39,480.67
2.08%
Dow Jones
42,221.88
0.92%
Iron Ore
104.20
(1.13%)
USD/AUD
0.66
(0.9%)
Hang Seng
20,538.38
(1.22%)
Lithium
45.22
0.51%
Gold
2,738.70
(0.5%)
Copper
4.38
(2.03%)
Oil
70.80
(1.69%)
Bitcoin
72,887.10
5.07%
FTSE 100
8,277.85
1.29%
Nikkei 225
39,480.67
2.08%
Dow Jones
42,221.88
0.92%
Iron Ore
104.20
(1.13%)
USD/AUD
0.66
(0.9%)
Hang Seng
20,538.38
(1.22%)
Lithium
45.22
0.51%
Gold
2,738.70
(0.5%)
Copper
4.38
(2.03%)
Oil
70.80
(1.69%)
Bitcoin
72,887.10
5.07%
FTSE 100
8,277.85
1.29%
Nikkei 225
39,480.67
2.08%
Dow Jones
42,221.88
0.92%
Iron Ore
104.20
(1.13%)
USD/AUD
0.66
(0.9%)
Hang Seng
20,538.38
(1.22%)
Lithium
45.22
0.51%
Gold
2,738.70
(0.5%)
Copper
4.38
(2.03%)
Oil
70.80
(1.69%)
Bitcoin
72,887.10
5.07%
FTSE 100
8,277.85
1.29%
Nikkei 225
39,480.67
2.08%
Dow Jones
42,221.88
0.92%
Iron Ore
104.20
(1.13%)
USD/AUD
0.66
(0.9%)
Hang Seng
20,538.38
(1.22%)
Lithium
45.22
0.51%
Gold
2,738.70
(0.5%)
Copper
4.38
(2.03%)
Oil
70.80
(1.69%)
Bitcoin
72,887.10
5.07%
FTSE 100
8,277.85
1.29%
Nikkei 225
39,480.67
2.08%
Dow Jones
42,221.88
0.92%
Iron Ore
104.20
(1.13%)
USD/AUD
0.66
(0.9%)
Hang Seng
20,538.38
(1.22%)
Lithium
45.22
0.51%
Gold
2,738.70
(0.5%)
Copper
4.38
(2.03%)
Oil
70.80
(1.69%)
Bitcoin
72,887.10
5.07%
FTSE 100
8,277.85
1.29%
Nikkei 225
39,480.67
2.08%
Dow Jones
42,221.88
0.92%
Iron Ore
104.20
(1.13%)
USD/AUD
0.66
(0.9%)
Hang Seng
20,538.38
(1.22%)
Lithium
45.22
0.51%
Gold
2,738.70
(0.5%)
Copper
4.38
(2.03%)
Oil
70.80
(1.69%)
Bitcoin
72,887.10
5.07%
FTSE 100
8,277.85
1.29%
Nikkei 225
39,480.67
2.08%
Dow Jones
42,221.88
0.92%
Iron Ore
104.20
(1.13%)
USD/AUD
0.66
(0.9%)
Hang Seng
20,538.38
(1.22%)
Lithium
45.22
0.51%
Gold
2,738.70
(0.5%)
Copper
4.38
(2.03%)
Oil
70.80
(1.69%)
Bitcoin
72,887.10
5.07%
FTSE 100
8,277.85
1.29%
Nikkei 225
39,480.67
2.08%
Dow Jones
42,221.88
0.92%
Iron Ore
104.20
(1.13%)
USD/AUD
0.66
(0.9%)
Hang Seng
20,538.38
(1.22%)
Lithium
45.22
0.51%
Gold
2,738.70
(0.5%)
Copper
4.38
(2.03%)
Oil
70.80
(1.69%)
Bitcoin
72,887.10
5.07%
FTSE 100
8,277.85
1.29%
Nikkei 225
39,480.67
2.08%
Dow Jones
42,221.88
0.92%
Iron Ore
104.20
(1.13%)
USD/AUD
0.66
(0.9%)
Hang Seng
20,538.38
(1.22%)
Lithium
45.22
0.51%
Gold
2,738.70
(0.5%)
Copper
4.38
(2.03%)
Oil
70.80
(1.69%)
Bitcoin
72,887.10
5.07%
FTSE 100
8,277.85
1.29%
Nikkei 225
39,480.67
2.08%
Dow Jones
42,221.88
0.92%
Iron Ore
104.20
(1.13%)
USD/AUD
0.66
(0.9%)
Hang Seng
20,538.38
(1.22%)
Lithium
45.22
0.51%
Gold
2,738.70
(0.5%)
Copper
4.38
(2.03%)
Oil
70.80
(1.69%)
Bitcoin
72,887.10
5.07%
FTSE 100
8,277.85
1.29%
Nikkei 225
39,480.67
2.08%
Dow Jones
42,221.88
0.92%
Iron Ore
104.20
(1.13%)
USD/AUD
0.66
(0.9%)
Hang Seng
20,538.38
(1.22%)
Lithium
45.22
0.51%
Gold
2,738.70
(0.5%)
Copper
4.38
(2.03%)
Oil
70.80
(1.69%)
Bitcoin
72,887.10
5.07%
FTSE 100
8,277.85
1.29%
Nikkei 225
39,480.67
2.08%
Dow Jones
42,221.88
0.92%
Iron Ore
104.20
(1.13%)
USD/AUD
0.66
(0.9%)
Hang Seng
20,538.38
(1.22%)

Neuren Pharmaceuticals (ASX: $NEU) capitalizes on priority review voucher sale

Neuren Pharmaceuticals cashes in on PRV sale


Neuren Pharmaceuticals (ASX:NEU) is set to benefit from the sale of a Rare Pediatric Disease Priority Review Voucher for US$150 million. The sale is executed through its partnership with Acadia Pharmaceuticals. Neuren will receive one-third of the net proceeds from this transaction, highlighting the company's ongoing commitment to developing therapies for serious neurological disorders.

Neuren's strategic outlook and development goals


Neuren Pharmaceuticals, in partnership with Acadia Pharmaceuticals, is selling a Rare Pediatric Disease Priority Review Voucher for US$150 million. Neuren will receive a substantial portion of the proceeds. The voucher was granted following FDA approval of DAYBUETM for Rett syndrome treatment. Neuren focuses on developing treatments for serious neurological disorders with limited options, benefiting from orphan drug designations. Their second candidate, NNZ-2591, is progressing in Phase 2 trials for various syndromes. Neuren's strategic partnerships and regulatory incentives like the PRV play a crucial role in advancing their mission to provide new therapies for rare conditions.

Executive commentary on strategic transaction


This transaction represents significant value realization for Neuren and validates our strategic approach in partnering to advance therapies for neurological disorders.

NEUREN PHARMACEUTICALS LIMITED
NEU | ASX | Health Care
13.271(+8.15%)
At close 05/11 (AEDT)
Market cap
$1.7B
Volume
751,280
DY Yield
PE Ratio
13.968422
52 Week Range
12.02 - 25.95
1YR Return
N / A

0 Comments
Inline Feedbacks
View all comments
Social Media Auto Publish Powered By : XYZScripts.com

Stock Piper AI Index Coming Soon!

Join our Newsletter to gain exclusive insight and be notified once we are live.

By clicking Subscribe, you agree to our Terms & Conditions

ASX News, First And Fast.

Get all the latest market updates straight to your inbox.

By clicking Subscribe, you agree to our Terms & Conditions